CD70 Targeting Therapies Clinical Trials Insight 2025: 20+ CD70 Targeting Therapies In Clinical Trials
January 31, 2025 05:00 ET
|
Research and Markets
Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "CD70 Targeting Therapies Clinical Trials & Market Opportunity Insight 2025" report has been added to ResearchAndMarkets.com's offering. CD70...
CD47 Inhibitor Drug Clinical Trials Market Opportunity Outlook 2028, Competitive Analysis of Adagene, ALX, ImmuneOncia, ImmuneOnco, Light Chain Bioscience, Phanes, and Virtuoso,
January 29, 2025 06:14 ET
|
Research and Markets
Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028" report has been added to ResearchAndMarkets.com's offering. ...
Registration Now Open for Pharmacovigilance Europe Conference 2025: Regulatory Affairs, Risk Management And Clinical Trials (London, United Kingdom - May 21-22, 2025)
January 28, 2025 10:58 ET
|
Research and Markets
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Europe 2025: Innovation And Integration: Advancing Global Pharmacovigilance In The Digital Age" conference has been added to ...
Register Now for the Pharmacovigilance USA Conference 2025: Empowering Safety Through Innovation And Real-World Evidence: Shaping The Future Of Pharmacovigilance (Boston, US - July 22-23, 2025)
January 28, 2025 10:54 ET
|
Research and Markets
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Pharmacovigilance USA 2025: Empowering Safety Through Innovation And Real-World Evidence: Shaping The Future Of Pharmacovigilance" conference has been...
First Participant Dosed in Tisento Therapeutics’ Global Phase 2b PRIZM Study Evaluating Zagociguat for the Treatment of MELAS
January 27, 2025 07:00 ET
|
Tisento Therapeutics Inc
The first patient has been dosed in Tisento's global Phase 2b PRIZM study investigating zagociguat in MELAS.
Recombinant Cell Culture Supplements Research Report 2024: Products, Applications, End-Users, and Regional Analysis - Global Market to Reach $3.17 Billion by 2035
January 27, 2025 04:24 ET
|
Research and Markets
Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Recombinant Cell Culture Supplements Market by Product, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's...
Axiom Brain Health and Global Alzheimer’s Platform Foundation Celebrate the Next Chapter in Innovative Research in Tampa
January 24, 2025 10:29 ET
|
Global Alzheimer’s Platform Foundation®
Tampa, Fla., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Axiom Brain Health (Axiom) and the Global Alzheimer’s Platform Foundation® (GAP) celebrated the next chapter in neurodegenerative research at the...
Pharmaceutical Impurity Synthesis and Isolation Services Market Analysis and Segment Forecasts 2025-2030: Global Market for Pharmaceutical Impurity Testing on Track for 8.1% Annual Growth
January 24, 2025 04:01 ET
|
Research and Markets
Dublin, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Impurity Synthesis And Isolation Services Market Size, Share & Trends Analysis Report By Service, By Impurity Type, By Technique, By...
Global Biotech Handbook 2025 Reveals Evolving Trends and Strategies for 70+ Countries
January 23, 2025 12:35 ET
|
Research and Markets
Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Global Biotech Handbook 2025" has been added to ResearchAndMarkets.com's offering. The fully revised and expanded Global Biotech Handbook provides...
Beckman Coulter Diagnostics Joins the Transformative Bio-Hermes-002 Study as New Partner
January 23, 2025 09:01 ET
|
Global Alzheimer’s Platform Foundation®
Washington D.C., Jan. 23, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Beckman Coulter Diagnostics as a strategic partner in the Bio-Hermes-002...